Publications by authors named "Susan J Kelly"

Claim this Profile
D
Diagnostic Implications and Correlates of Plasma Adenosine Deaminase 2 Activity and ADA2 Variants.
Jian Yue, Courtney E LeSon, Casey A Rimland, Kailey Brodeur, Rachel Weng, Susan J Kelly

Arthritis Rheumatol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sequence-Based Screening of Patients With Idiopathic Polyarteritis Nodosa, Granulomatosis With Polyangiitis, and Microscopic Polyangiitis for Deleterious Genetic Variants in ADA2.
Oskar Schnappauf, Natalia Sampaio Moura, Ivona Aksentijevich, Monique Stoffels, Amanda K Ombrello, Susan J Kelly

Arthritis Rheumatol· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deficiency of Adenosine Deaminase 2 (DADA2), an Inherited Cause of Polyarteritis Nodosa and a Mimic of Other Systemic Rheumatologic Disorders.
Hasan Hashem, Susan J Kelly, Nancy J Ganson, Michael S Hershfield

Curr Rheumatol Rep· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Extending the Clinical Phenotype of Adenosine Deaminase 2 Deficiency.
Tal Ben-Ami, Shoshana Revel-Vilk, Rebecca Brooks, Avraham Shaag, Michael S Hershfield, Susan J Kelly

J Pediatr· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adenosine deaminase type 2 deficiency masquerading as GATA2 deficiency: Successful hematopoietic stem cell transplantation.
Amy P Hsu, Robert R West, Katherine R Calvo, Jennifer Cuellar-Rodriguez, Mark Parta, Susan J Kelly

J Allergy Clin Immunol· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Visceral leishmaniasis in an infant following a holiday trip to Spain.
Johannes Trück, Charlotte Rampton, Susan Jane Kelly, Dominic Kelly

BMJ Case Rep· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hematopoietic stem cell transplantation rescues the immunologic phenotype and prevents vasculopathy in patients with adenosine deaminase 2 deficiency.
Lien Van Eyck, Michael S Hershfield, Diana Pombal, Susan J Kelly, Nancy J Ganson

J Allergy Clin Immunol· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early-onset stroke and vasculopathy associated with mutations in ADA2.
Qing Zhou, Dan Yang, Amanda K Ombrello, Andrey V Zavialov, Camilo Toro, Susan J Kelly

N Engl J Med· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Induced and pre-existing anti-polyethylene glycol antibody in a trial of every 3-week dosing of pegloticase for refractory gout, including in organ transplant recipients.
Michael S Hershfield, Nancy J Ganson, Susan J Kelly, Edna L Scarlett, Denise A Jaggers

Arthritis Res Ther· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Uric acid is a danger signal of increasing risk for osteoarthritis through inflammasome activation.
Anna E Denoble, Kim M Huffman, Thomas V Stabler, Susan J Kelly, Michael S Hershfield

Proc Natl Acad Sci U S A· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treating gout with pegloticase, a PEGylated urate oxidase, provides insight into the importance of uric acid as an antioxidant in vivo.
Michael S Hershfield, L Jackson Roberts, Nancy J Ganson, Susan J Kelly, Ines Santisteban

Proc Natl Acad Sci U S A· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SLE with C1q deficiency treated with fresh frozen plasma: a 10-year experience.
Puja Mehta, Peter J Norsworthy, Angela E Hall, Susan J Kelly, Mark J Walport

Rheumatology (Oxford)· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics and pharmacodynamics of intravenous PEGylated recombinant mammalian urate oxidase in patients with refractory gout.
John S Sundy, Nancy J Ganson, Susan J Kelly, Edna L Scarlett, Claudia D Rehrig

Arthritis Rheum· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Control of hyperuricemia in subjects with refractory gout, and induction of antibody against poly(ethylene glycol) (PEG), in a phase I trial of subcutaneous PEGylated urate oxidase.
Nancy J Ganson, Susan J Kelly, Edna Scarlett, John S Sundy, Michael S Hershfield

Arthritis Res Ther· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diabetes insipidus in uricase-deficient mice: a model for evaluating therapy with poly(ethylene glycol)-modified uricase.
Susan J Kelly, Marielle Delnomdedieu, Michael I Oliverio, L David Williams, Mark G P Saifer

J Am Soc Nephrol· May 2001

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis